Company: PharmaEssentia Corporation

Bloomberg ticker: 6446 TT

Market cap: US$7,259m

Background: PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer. The company was founded in 2003 by a group of Taiwanese-American executives and scientists from American biotech and pharmaceutical companies.

World Class Benchmarking of PharmaEssentia Corp

---

---

 

• Profitable Growth rank of 6 was up compared to the prior period’s 9th rank
• This is below average performance compared to 350 medium Health Care companies worldwide
• Profitability rank of 6 was worse than its Growth rank of 2
• Profitability rank of 6 was up compared to the prior period’s 9th rank
• This is below average performance compared to peers
• Growth rank of 2 was the same compared to the prior period’s 2nd rank
• This is World Class performance compared to peers

 

---

DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.